Back

RNA therapeutics CDMO market to reach $40.68 billion by 2035 at 9.86% CAGR

Verifying
  • SNS Insider forecasts the RNA therapeutics CDMO market will reach $40.68 billion by 2035.
  • The market was valued at $15.90 billion in 2025 and carries a 9.86% CAGR forecast.
  • North America held approximately 46% of global revenue in 2025, while Asia-Pacific leads growth projections.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.